This patent covers fetally derived neuronal stem cells, alone, and after transfection with therapeutic genes. These stem cells may be transfected in order to secrete trophic factors that would allow endogenous brain stem cells to proliferate. On the other hand, they may be transfected with anti-apoptotic genes such as Xiap. Xiap transfection would allow the cells to maintain viability.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.